A GP guide to Botox for neurological conditions
PBS listings for botulinum toxin have grown in recent years, reflecting its safety and efficacy in treating a wide variety of neurological conditions.
The botulinum toxins, serotypes A-G, are seven neurotoxic proteins produced by bacteria of the genus clostridium.
All types disrupt neurotransmitter release by interfering with the exocytosis of vesicles from neurons.1